Carregant...
Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis
Several lines of evidence have supported the role of immunological mechanisms in the pathogenesis of multiple sclerosis (MS) and new immunomodulatory strategies for its treatment, e.g. subcutaneous application of interferon (IFN)-β, have emerged. We investigated the ability of peripheral blood monon...
Guardat en:
| Publicat a: | J Neurol Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Science B.V.
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127026/ https://ncbi.nlm.nih.gov/pubmed/9168171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0022-510X(97)05383-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|